Teladoc Health Reports Q2 2025 Revenue Decline of 2% YoY, Net Loss of $32.7 Million, EPS at $0.19

Reuters
2025/07/30
Teladoc Health Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue Decline of 2% YoY, Net Loss of $32.7 Million, EPS at $0.19

Teladoc Health Inc., a leader in virtual care, reported its financial results for the second quarter of 2025, showing a revenue of $631.9 million, marking a 2% decline compared to the same period in 2024. The company posted a net loss of $32.7 million for the quarter, translating to a loss of $0.19 per share. Adjusted EBITDA for the second quarter was $69.3 million, down 23% from the previous year. In terms of segment performance, the Integrated Care segment reported revenue of $391.5 million, reflecting a 4% increase year-over-year, with an adjusted EBITDA margin of 14.7%. Conversely, the BetterHelp segment's revenue decreased by 9% year-over-year to $240.4 million, with an adjusted EBITDA margin of 4.9%. Teladoc Health also announced that they used $550.6 million in cash to retire convertible senior notes due in the second quarter of 2025. Additionally, on July 17, 2025, the company entered into a credit agreement for a $300.0 million senior secured revolving credit facility to enhance financial and operational flexibility. For the full year of 2025, Teladoc Health expects revenue between $2.501 billion and $2.548 billion, with an adjusted EBITDA range of $263 million to $294 million. The net loss per share is projected to be between $1.35 and $1.00. The company's outlook anticipates revenue growth for its Integrated Care segment at 1.75% to 3.25%, while the BetterHelp segment is expected to see a revenue decline of 9.20% to 6.80%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teladoc Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9502563-en) on July 29, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10